3 days AbbVie cuts 2024 profit forecast on acquisition expenses Investing.com AbbVie cuts 2024 profit forecast on acquisition expenses. AbbVie (ABBV) X
3 weeks AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily X
1 month The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks X
1 month AbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025 MarketWatch X
2 months AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback Investor's Business Daily X
2 months Aldeyra’s FDA Resubmission And AbbVie Option Revitalize Reproxalap’s Prospects Seeking Alpha X
2 months AbbVie’s Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio Yahoo Finance X
2 months Bristol Rockets 11% As Investors Question AbbVie’s $8.7 Billion ‘Mistake’ Investor's Business Daily X